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Paternal exposure to solvents, pesticides, and
metals has been associated in animals and
humans with the occurrence of spontaneous
abortion, low birth weight, birth defects,
childhood leukemia, brain cancer, change in
the male:female sex ratio of offspring, and
other end points related to growth and
development. Certain paternal occupa-
tions—rubber worker, petroleum worker,
agricultural chemical worker, painter,
welder, and janitor—have been particularly
implicated as detrimental to the reproductive
health of men (1). The reproductive hazards
of occupational exposure have been recog-
nized by the National Institute for
Occupational Safety and Health (NIOSH)
as a priority area in need of further study.
The National Occupational Research
Agenda, coordinated by NIOSH, was estab-
lished in 1996 to outline the research priori-
ties that can lead to improved worker safety
and health in 21 key areas of occupational
health (2). One of the 21 priority research
areas is fertility and pregnancy abnormalities,
which includes male reproductive health.
However, exposure to environmental haz-
ards is not limited to the workplace. Potential
sources of exposure include food, air, water,
soil, and hobbies. Individuals may have multi-
ple exposures that in many cases occur chron-
ically and at low doses. The reproductive
health implications of chronic exposures to
reproductive toxicants are not well document-
ed and, in general, the mechanisms of toxicity
are either poorly understood or unknown.
Reports of declining sperm counts over
the past 50 years and other disturbing
trends alerted scientists to the possibility
that exposure to chemicals in the environ-
ment may damage male reproductive health.
Testicular cancer, the most common malig-
nancy in men 15–44 years of age (3), has
increased markedly in incidence in this cen-
tury in virtually all countries studied. The
incidence of hypospadias, a developmental
malformation of the male urethra, appears
to be increasing worldwide. Cryptorchidism
(undescended testicle), another develop-
mental defect, may have increased in some
human populations and appears to be
increasing in wildlife (4,5). 
The causes of these trends have not been
identified and relevant toxicologic data
about male reproductive effects of environ-
mental toxicants are limited. Recent research
efforts have focused on the possibility that
exposures to hormonally active compounds,
particularly during childhood and in utero,
are to blame, at least in part, for changes in
semen quality, increasing rates of testicular
cancer, and malformations of the male uro-
genital tract. The ability to investigate envi-
ronmental determinants of these indicators
of male reproductive health is currently lim-
ited by available methodologies and data.
Male reproductive health is not measur-
able by any one variable. The male repro-
ductive system is complex; its development
is hinged on precisely timed events and full
reproductive capacity is dependent on dis-
parate physiologic processes. For example, an
accurate picture of male reproductive capaci-
ty and function cannot be obtained solely
through the measurement of a single sperm
count. It is more correctly characterized by a
variety of biologic markers, which together
provide a more comprehensive picture than
any outcome would on its own (6). In con-
sidering the state of male reproductive
health, researchers must look broadly at rele-
vant outcomes in addition to fertility,
including disturbances in neuroendocrine
hormone proﬁles, alterations in sexual func-
tioning, the occurrence of cancers, and con-
genital defects of the male reproductive tract.
As more information about the toxic effects
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The discovery in the mid-1970s that occupational exposures to pesticides could diminish or destroy
the fertility of workers sparked concern about the effects of hazardous substances on male reproduc-
tive health. More recently, there is evidence that sperm quantity and quality may have declined
worldwide, that the incidence of testicular cancer has progressively increased in many countries, and
that other disorders of the male reproductive tract such as hypospadias and cryptorchidism may
have also increased. There is growing concern that occupational factors and environmental chemical
exposures, including in utero and childhood exposures to compounds with estrogenic activity, may
be correlated with these observed changes in male reproductive health and fertility. We review the
evidence and methodologies that have contributed to our current understanding of environmental
effects on male reproductive health and fertility and discuss the methodologic issues which confront
investigators in this area. One of the greatest challenges confronting researchers in this area is assess-
ing and comparing results from existing studies. We elaborate recommendations for future research.
Researchers in the ﬁeld of male reproductive health should continue working to prioritize hazardous
substances; elucidate the magnitude of male reproductive health effects, particularly in the areas of
testicular cancer, hypospadias, and cryptorchidism; develop biomarkers of exposure to reproductive
toxins and of reproductive health effects for research and clinical use; foster collaborative interdisci-
plinary research; and recognize the importance of standardized laboratory methods and sample
archiving. Key words: hazardous substances, male reproductive health, research, semen quality.
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RESEARCH
Reviewof hazardous substances emerges, male
reproductive health may expand to include
additional as yet unidentiﬁed variables.
Semen quality, in particular, should be
considered in a more comprehensive man-
ner. Research studies in the past have looked
at sperm count (millions of sperm per milli-
liter of ejaculate) as the single measure of
male reproductive health. Although sperm
count is an important measure, there is a
need to examine semen quality as a whole.
Semen quality includes ejaculate volume,
sperm motility, sperm morphology, func-
tional variables, and tests of genetic integrity
or damage. An important and emerging
understanding in this field is that semen
quality varies within and between individu-
als. There are seasonal variations in semen
quality, and male fertility decreases some-
what with age. Abstinence preceding collec-
tion of a semen specimen plays a role in
semen quality, with days of abstinence corre-
lated to sperm count, sperm motility, and
ejaculate volume. Subjective evaluation of
some relevant outcomes, such as sperm mor-
phology, limits precise comparisons of sperm
quality. As automated systems are developed
for measuring such outcomes, straightfor-
ward, reliable, and truly comparable data
will be generated.
A comprehensive approach to exposure
assessment is also important because men are
exposed to complex combinations of poten-
tial reproductive toxicants and not simply to
isolated hazards. Most exposures are multi-
ple and overlapping. Moreover, chemicals
might interact with the male reproductive
system in different ways depending on other
toxicants present in the body. Until methods
to examine the effects of complex chemical
mixtures are developed, research that
examines one compound exclusively pro-
vides an incomplete picture of reproductive
health effects.
On 14–15 May 1998, the National
Institute of Environmental Health
Sciences/Superfund Basic Research Program
and the Mount Sinai School of Medicine
convened a conference, Hazardous Sub-
stances and Male Reproductive Health, to
develop strategies for understanding the
importance of environmental effects on male
reproductive health and fertility and to draft
an international research agenda. Other
sponsors of the conference were the U.S.
Environmental Protection Agency (U.S.
EPA), the National Institute for Occu-
pational Safety and Health, the Agency for
Toxic Substances and Disease Registry, and
the New York Academy of Medicine. The
research ﬁndings and recommendations aris-
ing from the conference provided a founda-
tion on which the following framework for
research was developed.
Ecoepidemiology: The
Complementary Evidence of
Reproductive Toxicity in
Wildlife
Environmental pollutants have been linked
to adverse male reproductive effects in
wildlife species in classes from invertebrates
to mammals (7). Although such reproduc-
tive outcomes have been studied most inten-
sively in amphibians and reptiles, related
male reproductive disorders occur in many
species of wildlife. The causes of many of
these disorders are unknown, but exposure
to hormonally active agents in the environ-
ment is one possible explanation. The
methods of ecoepidemiology address the
challenges of evaluating the contributions of
environmental pollutants to speciﬁc disease
states in wildlife not living in controlled con-
ditions (8). An ecoepidemiologic approach
allows for the distinction between genetic
causes (which may be enhanced by inbreed-
ing in isolated populations resulting from
isolation of subpopulations) and environ-
mental causes of disease. Such an approach
must begin with ﬁeld evaluation, move into
the laboratory, and then look at compounds
on a mechanistic level.
The Lake Apopka alligator is one of the
best-known wildlife species in which envi-
ronmental xenoestrogens appear to have
damaged the male reproductive system. The
freshwater Lake Apopka in Florida is
adjacent to the former Tower Chemical
Company, which is now a Superfund site.
From 1970 to 1980, a pesticide mixture
containing high levels of DDT and its
metabolites contaminated the area. Research
comparing alligators from Lake Apopka to
those in other Florida lakes found that Lake
Apopka juvenile alligators have signiﬁcantly
smaller penis size as well as abnormalities in
gonadal morphology and lower concentra-
tions of plasma testosterone (9). Although
the exact cause has not been determined,
these alligators have significantly elevated
serum concentrations of organochlorine pes-
ticides compared to alligators at other lakes in
Florida. The Lake Apopka alligators also have
the breakdown product of DDT (DDE)
stored in their body fat. Environmental
xenoestrogens and antiandrogens such as
these may contribute to abnormal or subnor-
mal reproductive system development, and
appear to act on the males speciﬁcally during
embryonic development (10,11).
The Florida panther is another species in
which environmental pollutants may be the
cause of signiﬁcant male reproductive effects
(11). The endangered Florida panther suffers
from inbreeding and vastly reduced habitat.
The remaining population, estimated at only
30–50 individuals in 1995, exhibits a variety
of problems, including reproductive and
endocrine disorders (11). The males have an
extremely high rate of cryptorchidism (esti-
mated as 90% in 1995), as well as low ejacu-
late volume; low sperm concentration; poor
sperm motility; and high proportion of
sperm with morphologic abnormalities.
Because of the small population size and the
reduced habitat area, researchers have
hypothesized that inbreeding may be the
cause of the myriad health problems, but
another possible explanation is exposure to
environmental xenoestrogens. Florida pan-
thers eat hogs, deer, armadillos, and rac-
coons. Raccoons are suspected to account for
much of the exposure to environmental
xenoestrogens. In that area raccoons, which
eat fish, bioaccumulate mercury as well as
endocrine-disrupting pesticides (12,13).
Although the causes of the reproductive
problems in the Florida panther have not
been identiﬁed, estrogen mimics and antian-
drogens in the environment are emerging as
a strong possibility. This has significant
implications for other wildlife species as well
as for humans.
Male reproductive problems in wildlife
provide a complementary picture to human
health effects. Such trends are helpful in
evaluating environmental threats to human
reproductive health, and have enabled
researchers to focus on substances that,
because of their effects on wildlife, are likely
to pose reproductive health hazards in men.
Evidence of Environmental
Impact on Male Reproductive
Health in Humans
During the past decade, signiﬁcant attention
has focused on reported trends of declining
male reproductive health. Almost all cancer
registries in the Western world have noted
remarkable increases in testicular cancer inci-
dence (3). Several indications of decreasing
semen quality have been noted (14–18).
There are also data to suggest that the inci-
dence of certain urogenital abnormalities,
including hypospadias and cryptorchidism,
have become more common (19). The fact
that these reported changes in male repro-
ductive health occurred concurrently within
a relatively short period of time suggests that
common environmental factors may be of
importance. Normal sexual differentiation,
normal development of the gonads, and nor-
mal postnatal development are essential for
normal reproductive function in adulthood;
therefore, it has been suggested that a com-
mon fetal factor could play a role in all of the
observed trends (19). Based on epidemiologic
evidence from studies of children of mothers
who were exposed to diethylstilbestrol in
early pregnancy (20,21) and experimental
evidence from the administration of synthetic
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hypothesized that hormonally active agents,
which are ubiquitously distributed in the
environment, could play an etiologic role.
Researchers from several countries, including
Denmark, the United Kingdom, and the
United States, have published reports that
delineate the current state of knowledge and
provide suggestions for further research to
address these hypotheses (19). 
Testicular cancer. Testicular cancer is the
most common malignancy among men
15–44 years of age, with a peak incidence
between 18 and 35 years of age (27,28).
Environmental inﬂuences are likely to play
an important causal role in this disease,
which has shown marked geographic varia-
tion (29). Testicular cancer incidence is
highest in Denmark (30,31), Switzerland
(32), and New Zealand (33), with incidence
rates of up to 8 per 100,000 per year, and
the evidence is overwhelming that testicular
cancer incidence has increased rapidly in vir-
tually all countries studied (3). 
The increases in incidence cannot be
attributed to improvements in diagnosis or
surveillance because the observed increases
are too consistent and too large and because
the principal means of diagnosis has been
and remains the detection of a testicular mass
on direct physical examination. In the
United States, for example, the testicular can-
cer incidence rate among white active-duty
servicemen 17–44 years of age increased by
61% from the 1970s to the 1990s (34). This
increase in incidence was most striking for
those 30–-34 years of age, in whom testicular
cancer rates doubled during a time in which
there was no change in procedures for diag-
nostic detection. The rising incidence is
particularly disturbing given the otherwise
careful physical screening and good health of
this young adult male population.
Increases in the incidence of testicular
cancer have not been uniformly reported
among all men. The incidence of testicular
cancer in Nigeria, for example, is 0.1 per
100,000 per year (35). African Americans in
the United States also have had consistently
low incidence over time. Between 1973 and
1996, for example, rates of testicular cancer
increased 51.2% in white men and the rates
for black men increased 17.3% (36).
Although genetics almost certainly plays a
major role in the etiology of the disease,
other etiologies, including environmental fac-
tors, need to be elucidated to explain why,
for example, major differences in testicular
cancer rates exist among the relatively geneti-
cally homogenous Scandinavian countries.
Increases in testicular cancer rates are not
recent phenomena. A doubling in incidence
was documented in Denmark within 25
years after the initiation of cancer registration
in 1943 (3). Mortality data from Great
Britain show an increase in mortality due to
testicular cancer beginning in the 1920s
(37). These mortality data raise an impor-
tant distinction: if environmental risk factors
play a role in testicular cancer incidence, rel-
evant exposures must therefore have existed
since the turn of the century. This would
make it less likely that organochlorines such
as DDT and other endocrine-disrupting
chemicals are possible etiologic agents. 
Because testicular cancer occurs in young
adults, major etiologic factors may operate
early in life, perhaps even in utero (3).
Trends in testicular cancer suggest that life-
time exposure to environmental risk factors
appears more strongly related to birth cohort
than to year of diagnosis (3), implying that
early exposures may be most relevant for the
development of cancer. Such an observation
has important implications for prevention.
Efforts would have to be aimed toward
women and men of childbearing age, preg-
nant women, and neonates. Possible etio-
logic agents for testicular cancer include
abnormal sex hormone exposure related to
endocrine disruptors in the environment,
maternal parity (38) and age (39), high or
low birth weight (40), age at puberty (41),
use of the pesticides atrazine (42) and N,N-
diethyl-m-toluamide (43), and exposure to
workplace hydrocarbon (44) and polyvinyl
chloride (45).
Testicular cancer disproportionately
affects men with undescended testis (cryp-
torchidism), Klinefelter syndrome, hypospa-
dias, and infertility. The risk of developing
testicular cancer rises dramatically in men
with disorders of sexual gonadal develop-
ment (46). These include mixed gonadal
dysgenesis, androgen insensitivity, and male
pseudohermaphrodism (47). Nearly all of
these conditions are also characterized by
delayed differentiation of the testicle and
infertility. 
Epidemiologic studies have reported the
relative risk of testicular cancer in men with
cryptorchidism as 3–14 times the normal
expected incidence (39). In men with unilat-
eral cryptorchidism, the contralateral nor-
mally descended testicle is also at an
increased risk of developing testicular cancer.
Between 5 and 10% of men with unilateral
cryptorchidism develop testicular cancer in
the contralateral testicle and in nearly 50%
of men with bilateral testicular cancer, a his-
tory of cryptorchidism is present. This
observation is consistent with the hypothesis
that the inciting events resulting in cryp-
torchidism have a negative impact on the
normal development of both testes (47).
Testicular cancer patients have much
poorer semen quality than other cancer
patients, and a recent epidemiologic study
shows that men who have testicular cancer
are subfertile even before they develop clini-
cally detectable cancer (48). This suggests
causal factors shared by both subfertility and
testicular cancer (49). Research is ongoing to
explore new genetic markers for early detec-
tion of carcinoma in situ cells in semen, as
well as to deﬁne the role of hormonal assays
(e.g., inhibin-B) as screening tools for testic-
ular cancer and carcinoma in situ. 
Hypospadias and cryptorchidism. Two
male genital birth defects, hypospadias and
cryptorchidism, both apparently represent-
ing mild degrees of feminization, have
become important in the ongoing debate
regarding the signiﬁcance of endocrine dis-
ruptors or other environmental inﬂuences on
male development (50). Several researchers
have reported increases in each of these
defects in the past three decades (4,51). To
evaluate the hypothesis of common etiolo-
gies, pre- and perinatal determinants of
hypospadias, cryptorchidism, testicular can-
cer, and infertility are under investigation.
Abnormal sex hormone exposure during
critical periods of development has been pos-
tulated as a likely shared pathologic mecha-
nism (19).
Hypospadias is a developmental malfor-
mation in which the urethra opens on the
underside of the penis or on the perineum. If
untreated, hypospadias can lead to urinary
stricture, infection, and difﬁculties with ejac-
ulation. Reports of increasing rates of
hypospadias during the 1960s, 1970s, and
1980s have raised concerns about the
dependability of surveillance systems, espe-
cially regarding inconsistencies in diagnosis
due to a classiﬁcation scheme that depends
on the distance of the urethra opening to the
tip of the penis. Hypospadias, particularly in
the mildest degree, may be incorrectly classi-
ﬁed by clinicians. Despite the difﬁculties of
using surveillance system data, however, it
appears that rates of hypospadias are increas-
ing worldwide. The increasing rates do not
solely reﬂect improvements in reporting and
diagnosis, because there are increases for
severe hypospadias as well as for mild cases.
Data from a large number of countries
address the questions of whether increases in
hypospadias are continuing and whether the
direction of trend lines is correlated with
increasing industrialization. The International
Clearinghouse of Birth Defects Monitoring
Systems (Rome, Italy), which collects data
from 29 countries on five continents, has
assembled data that form the basis of an
analysis of global trends in hypospadias. The
incidence of hypospadias does not appear to
be associated with industrialization (as mea-
sured by gross domestic product), although
there has been an increase in reported
hypospadias rates in recent decades in the
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Hypospadias rates increased in 18 of 29 sys-
tems (62%) and declined in 11 systems,
although the increases may have slowed or
stopped since 1985. Whereas improved
reporting and diagnosis cannot account for
the increases, possible causes of the upward
trend in hypospadias rates include demo-
graphic changes and endocrine disruption,
among others (52).
Cryptorchidism, another male develop-
mental defect, is characterized by the failure
of one or both testicles to descend into the
scrotum. Cryptorchidism is a well-established
risk factor for subfertility and testicular can-
cer, strongly suggesting a common etiology
affecting germ cell development. Because the
defect resolves spontaneously by the first
birthday in > 70% of affected infants, there
are inconsistencies in its diagnosis. If the con-
dition is diagnosed before the ﬁrst birthday,
or if gestational age is miscalculated in
premature babies, there may be an overesti-
mation of the incidence rate. Although the
incidence of cryptorchidism does not appear
to be increasing worldwide in humans, data
on this defect are limited, and two U.S. sur-
veillance systems have shown marked increas-
es (52). The defect does appear to be rising in
wildlife populations such as the Florida pan-
ther (11), and demasculinization and femi-
nization have been linked in other wildlife
populations to environmental exposure to
endocrine disruptors (7).
Semen quality. Reports suggesting that
sperm counts have declined in certain areas
of industrialized countries throughout the
world (14,16–18,53–56) have contributed
to concern about a possible worldwide
decline in human semen quality. A meta-
analysis by Carlsen et al. (14) in 1992
reported a worldwide decline in sperm
counts over the preceding 50 years, conclud-
ing that mean sperm concentrations had
decreased by almost 50% from 1940 to
1990. A 1995 study reported a 30% decrease
in sperm concentration in Paris over a 20-
year period among fertile sperm donors from
a single sperm bank (53). Numerous
researchers have attempted to determine
whether this apparent decline is real or due
to unrecognized biases in data collection and
analysis (18,57).
Confounding variables may account for
the observed ﬁndings. Potential confounders
include increasing donor age, duration of
abstinence, frequency of ejaculation, and
even the season of sample collection, all of
which inﬂuence sperm variables. Other sug-
gested confounders include smoking, radia-
tion exposure, stress, ethnicity, and a variety
of physical conditions including varicocele,
infection, and genital abnormalities such as
hypospadias and cryptorchidism. In addition,
differences in methodology used to perform
the semen analysis may produce inaccura-
cies. For example, there is interobserver vari-
ability when comparing sperm counts from
different databanks, and there are measure-
ment inaccuracies of up to 30% depending
on the counting chamber (58).
In a 1996 paper, Fisch et al. (58) exam-
ined geographic variability as a potential
confounding variable that may signiﬁcantly
affect reported temporal trends in sperm
counts. The authors observed that sperm
count within the United States depended on
geographic location, with the highest counts
occurring in New York City samples, and
suggested that the observed differences in
semen quality may simply reﬂect the cluster-
ing of significant geographic determinants.
Theories explaining the apparent geographic
disparities in sperm counts are currently only
speculative, and include environmental,
socioeconomic, racial, and methodologic dif-
ferences (18,59). Fisch et al. (58) reported
yearly fluctuations in mean sperm counts
and birth rates (60), suggesting that this may
be a more important variable than previously
considered.
Methods of Assessing Male
Reproductive Capacity 
Toxicants can affect the male reproductive
system at one of several sites or at multiple
sites. These sites include the testes, the acces-
sory sex glands, and the central nervous sys-
tem, including the neuroendocrine system.
There is no single all-encompassing marker of
reproductive capacity in men, and there is no
consensus among researchers about what con-
stitutes an appropriate battery of validated
and interpretable variables of male reproduc-
tive function for use in research and clinical
settings. We review the state of the science
and the methodologies with greatest promise
from three areas—experimental toxicology,
epidemiology, and chromosomal or genetic
toxicity.
The contribution of experimental mod-
els. The usefulness of experimental animal
models is usually perceived as limited to haz-
ard identification using the test protocols
specified by regulatory agencies. However,
animal models can also provide valuable sup-
port to reproductive risk assessment on
many other fronts. If the focus is on human
exposure, animal studies can be designed to
confirm reproductive toxicity when initial
observations in exposed humans are sugges-
tive of an adverse effect. Furthermore, such
observations can be extended across a wide
range of exposures in animals, using any
route of exposure and any speciﬁed dose ver-
sus time scenario. For example, when human
exposure is likely to be acute or intermittent,
animal models are ideal for deﬁning critical
exposure windows based on developmental
stage or for revealing the pathogenesis of an
effect at various times after exposure through
recovery. This is particularly important with
respect to male reproductive effects because
alterations in semen quality or fertility may
not become evident until some time after the
exposure, particularly if an early stage of
spermatogenesis is targeted. 
A rodent model is most commonly used
for the study of reproductive and develop-
mental toxicity (61). To use toxicology data
derived from animal studies to advantage in
risk assessment, it is critical to identify and
understand species-specific differences in
physiology and metabolism that may affect
the response to the toxicant in question. It is
also important to recognize that the genetic
homogeneity of rodents, although advanta-
geous in its lack of potential confounding
factors, makes it difﬁcult to study susceptible
subpopulations unless different strains are
studied. Nevertheless, rodent studies provide
valuable information about hazard identiﬁ-
cation, dose response, and critical thresholds
for fertility, and are often helpful for devel-
oping paradigms for human studies. Rodent
models have, for example, been used to
determine the relationship between sperm
end points and function (fertility) (62).
Determining that a substance is toxic to
the male reproductive system is only the ﬁrst
step: The next step is to examine its mecha-
nisms of toxicity. Mechanistic information
allows for predictions about the potential
toxicity of individual compounds or com-
plex mixtures in humans, for better under-
standing of the windows of vulnerability in
the development of the male reproductive
system, and for developments of possible
preventive or curative measures. 
Acute short-term exposure models com-
bined with serial exposure models give a
complete picture of the range of effects (61).
Exposing animals over a long period of time
allows for the detection of transgenerational
effects from chemicals, such as male-mediat-
ed developmental effects. If developmental
effects appear, researchers can go back and
administer a dose during that critical period
of development to refine knowledge about
how such problems occur. Early develop-
mental end points measurable in animal
research include anogenital distance at birth,
testis position, genital malformations, sec-
ondary sex characteristics, and serum hor-
mone levels. Acute short-term exposures, on
the other hand, can be useful for identifying
critical windows of exposure. Acute exposures
followed over time can help identify the
pathogenesis of a lesion, isolate the cell type
that is susceptible to damage (germ cells,
spermatocytes, or spermatid), and determine
genetic effects, including the repair capability
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best used for identifying the earliest
detectable pathologic changes in target
organs, cells, or processes. Multigeneration
studies, in particular continuous breeding
studies, yield the most thorough assessment
of the many complex processes that result in
reproductive and developmental toxicity. 
Epidemiologic approaches. Epidemiologic
methods for assessing the impact of haz-
ardous substances on male reproductive
health include a) questionnaires to determine
reproductive history and sexual function, b)
reproductive hormone proﬁles, and c) semen
analysis. The choice of appropriate method-
ologies to study the effects of reproductive
toxicants is predicated on the investigators’
understanding of several factors: the nature of
the exposed population; the source, the lev-
els, and the known routes of exposure; the
organ systems in which a toxicant exerts its
actions; the hypothesized mechanisms of a
toxicant’s actions; and the techniques avail-
able to assess the effects of toxicants in the
relevant organ systems (63,64). Table 1 out-
lines the methods currently available for
assessing the principal targets of male repro-
ductive toxicants in humans—the testes, the
accessory sex glands, the neuroendocrine sys-
tem, and sexual function. Researchers and
clinicians interested in male reproductive
health and fertility are using increasingly
sophisticated methods adapted from the
ﬁelds of assisted reproductive technology and
reproductive toxicology, including assays of
sperm function, genetic integrity, and bio-
markers of DNA damage. For population-
based studies involving occupational groups
or communities with environmental expo-
sures, issues related to the cost, validity, pre-
cision, and utility of these methods must be
carefully considered.
The testis, the site of sperm cell produc-
tion and the target organ for genetic damage,
is most often studied. Occupational exposures
to lead, dibromochloropropane, ethylene
dibromide, and glycol ethers affect sperm pro-
duction in humans (1,65–68). To establish
the extent of toxicity to the testis, researchers
can measure the size of the testis, obtain a
semen sample, or take a testicular biopsy.
Standard semen analyses (including semen
volume, sperm concentration, total sperm
count, motility, and morphology) have been
the primary research tools for studying the
effects of toxicants on the male reproductive
system. Epidemiologic studies have success-
fully utilized semen quality as a marker of
fertility (60,69) although not without prob-
lems (70–74) (e.g., potential selection bias
due to low compliance rates and substantial
intraindividual variability in semen variables
resulting in misclassiﬁcation based on the sta-
tic results of a single analysis). In contrast to
longitudinal studies as well as clinical evalua-
tions where more than one semen sample is
required (75), research has shown that in
cross-sectional epidemiologic investigations, a
single semen sample from each participant
generally is sufficient if obtained under
deﬁned conditions and according to a set pro-
tocol (72,73,76). Methodologic questions
regarding intraindividual variation and the
precision and reliability of assessment tech-
niques can be addressed to some extent.
Individual semen samples can be split and
replicate measurements made. The mean
value from multiple aliquots can be used and
intraclass correlation and coefﬁcients of varia-
tion can be determined. Individualized con-
tact and follow up with the study subjects, the
provision of ﬁnancial incentives, and the use
of mail-in containers that allow men to collect
the semen sample at home are factors that
may increase response rates in epidemiologic
studies (77).
As much as any other factor, uncertainty
in the results of studies addressing threats to
male reproductive health stems from debate
about the deﬁnition of normal semen quality
and whether or not expected ﬂuctuations are
distinguishable from diminished reproduc-
tive capacity resulting from hazardous expo-
sures (72,73,78,79). In epidemiology studies
conducted to investigate effects of an acci-
dental exposure, it may be difﬁcult to enroll
an appropriate unexposed control group. In
such cases, results obtained from exposed
populations can be interpreted with respect
to the reference values established for routine
semen measures by the World Health
Organization methods (80) and other well
established criteria (81). 
It has proved more difﬁcult, however, to
resolve questions about the validity of using
semen measures to assess human fertility
(59,69,82). Which semen variables are the
most sensitive with respect to perturbation
by toxicant exposure, and which are the
most predictive of human fertility? Can
threshold levels associated with impaired fer-
tility be deﬁned? Are shifts in sperm quantity
and quality within populations related to
measurable decreases in normal live births?
Some relevant information about these ques-
tions has been provided by animal models
(62). However, because these models rely on
observations of the group as a whole, they
have not been as useful in elucidating
intraindividual variability, which impedes
our ability to apply results from these models
to humans. The uncertainties associated
with traditional semen measures have led to
the recent development of assays of sperm
function and genetic integrity; these assays
may prove more sensitive and more speciﬁc
reﬂections of toxicant-induced effects (e.g.,
aneuploidy or reduced sperm motility) in
individuals (76,83). 
Although any of the commonly used epi-
demiologic study designs can be used to
study male reproductive health (e.g.,
case–control studies of occupational risk fac-
tors for congenital defects or other adverse
pregnancy outcomes and retrospective
cohort studies for cancers of the genitouri-
nary tract), the most promising current and
future initiatives use prospective cohort stud-
ies that are designed to test speciﬁc exposure-
outcome hypotheses (84). Currently, several
ongoing studies are addressing relationships
among measures of semen quality, fertility,
pregnancy outcomes, and exposures. These
investigations have been designed to take
into account potential confounders such as
geographic variability; factors related to the
female partner including abnormal menstru-
al cycle, previous treatment for infertility,
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Table 1. Assessment of male reproductive capacity in humans.
Endocrine Posttesticular Sexual 
Method of assessment system Testes eventsa function
Luteinizing hormone  – – –
Prolactin – – –
Testosterone – – –
Inhibin-B – – –
Sperm density – – –
Sperm morphology and morphometry – –
Sperm motility (% motile and velocity) – –
Sperm viability (vital stain and HOS) – – –
Semen volume – – –
Semen pH – – –
Marker chemicals from accessory glands – – –
Sperm function assaysb ––
Sperm genetic analysesc ––
Nocturnal penile measurements –––
Personal reproductive historyd –
Adapted from Schrader (67) and Schrader and Kesner (86). HOS, hyperosmotic swelling. 
aIncludes production of seminal plasma components by sex accessory glands and maturation of sperm in the epididymis. 
bIncludes acrosome reaction, hemizona assay of sperm binding, and sperm penetration assays. cIncludes sperm chromatin
stability assay, Comet assay, and assessment of chromosomal aneuploidy and nuclear microdeletions. dIncludes pubertal
development, paternity (pregnancy timing and outcomes), sexual function (erection, ejaculation, orgasm, and libido). and parity; contraception status; and absti-
nence interval (85).
The accessory sex glands, which include
the epididymis, prostate, and seminal vesicle,
may also be targets of toxicants (67). Ethylene
dibromide is one substance that affects the
accessory sex glands after occupational expo-
sure (68). Alterations in sperm viability, as
measured by eosin stain exclusion or by hypo-
osmotic swelling (86) or alterations in sperm
motility variables (72), suggest a problem
with the accessory sex glands. Biochemical
analysis of seminal plasma provides insights
into glandular function by evaluating marker
chemicals secreted by each respective gland
(67). For example, the epididymis is repre-
sented by glycerylphosphorylcholine, the sem-
inal vesicles by fructose, and the prostate
gland by zinc. Measures of semen pH and
volume provide additional general informa-
tion on the nature of seminal plasma, reﬂect-
ing posttesticular effects. A toxicant or its
metabolite may act directly on accessory sex
glands to alter the quantity or quality of their
secretions. Alternatively, the toxicant may
enter the seminal plasma and affect the sperm
or may be carried to the site of fertilization by
the sperm and affect the ova or conceptus.
The presence of toxicants or their metabolites
in seminal plasma can be analyzed using
atomic absorption spectrophotometry or gas
chromotography/mass spectrometry.
Impact on the neuroendocrine system is
another mechanism whereby toxicants can
disturb the male reproductive system. Lead,
stilbene, and kepone affect the endocrine sys-
tem in occupationally exposed men (87). To
establish the extent of endocrine dysfunction,
hormone levels can be measured in blood
and urine. The profile recommended by
NIOSH to evaluate endocrine dysfunction
associated with reproductive toxicity consists
of assessing serum concentrations of follicle-
stimulating hormone (FSH), luteinizing hor-
mone (LH), testosterone, and prolactin (67).
Because of the pulsatile secretion of LH,
testosterone, and to a much lesser extent
FSH, and the variability in the evaluation of
reproductive hormones, it is recommended
that three blood samples be drawn at set
intervals in the early morning and the results
pooled or averaged for clinical assessment
(88,89). In epidemiologic ﬁeld studies, how-
ever, multiple blood samples are impractical
and may decrease participation rates (90).
Alternatively, LH and FSH can be measured
in urine, providing indices of gonadotropin
levels that are relatively unaffected by pul-
satile secretion. However, if an exposure can
affect hepatic metabolism of sex steroid hor-
mones (91), urinary measures of excreted
testosterone metabolite (androsterone) or
estradiol metabolite (estrone-3-glucuronide)
are not recommended.
Future assessment of reproductive hor-
mones may extend to inhibin, activin, and
follistatin, polypeptides that are secreted pri-
marily by the gonads and that act on the
pituitary to increase (activin) or decrease
(inhibin and follistatin) FSH synthesis and
secretion. Within the gonads, these peptides
regulate steroid hormone synthesis and may
also directly affect spermatogenesis. Ongoing
studies are investigating the utility of serum
inhibin-B level as an important marker of
Sertoli cell function and in utero develop-
mental toxicity (92,93).
Other indicators of central nervous sys-
tem toxicity are reported alterations in sexual
function, including libido, erection, and ejac-
ulation. There is not much literature on
occupational exposures causing sexual dys-
function in men (67); however, there are sug-
gestions that lead, carbon disulﬁde, stilbene,
and cadmium can affect sexual function.
These outcomes are difficult to measure
because of the absence of objective measures
and because sexual dysfunction can be attrib-
uted to and affected by psychologic or physi-
ologic factors (67). 
Biomarkers of genetic damage. Biomarkers
of chromosomal and genetic damage are
increasingly used in the search to understand
abnormal reproductive health outcomes, in
part because of the possibility that there may
be identiﬁable genetic polymorphisms which
make an individual more susceptible to the
adverse reproductive effects from exogenous
substances. These assays provide promising
and sensitive approaches for investigating
germinal and potentially heritable effects of
exposures to agents and for conﬁrming epi-
demiologic observations on smaller numbers
of individuals. Efﬁcient technology for exam-
ining chromosomal abnormalities in sperm
has only been developed recently.
Chromosomal abnormalities are primari-
ly of two types: numerical and structural.
Both kinds can be attributed in some cases
to paternal factors. Karyotype studies have
shown that although oocytes demonstrate a
higher frequency of numerical chromosomal
abnormalities, human sperm demonstrate a
higher frequency of structural abnormalities
with less frequent numerical abnormalities
(94). In assessing sperm exposure to toxi-
cants, it is therefore imperative to assess
DNA structural integrity and not just chro-
mosomal count.
Aneuploidy is a chromosomal abnormal-
ity that causes pregnancy loss, perinatal
death, congenital defects, and mental retar-
dation. Aneuploidy, a disorder of chromo-
some count, is observed in approximately 1
in 300 newborns (95). It is speculated that
of all species, humans experience the highest
frequency of aneuploidy at conception, with
estimates ranging from 20 to 50% (95).
Spontaneous abortions occur in at least
10–15% of all clinically recognized pregnan-
cies. Of these, 35% contain chromosomal
aneuploidy. Despite such a high frequency,
there is little information about what causes
this abnormality in humans.
Paternal origins of aneuploidy and other
genetic abnormalities can be analyzed by
studying chromosome complements in
human sperm. Two types of analyses provide
data on chromosomal abnormalities in
human sperm: sperm karyotype analysis and
fluorescence in situ hybridization (FISH)
(94). Each technique has advantages and dis-
advantages. Sperm karyotyping is performed
after sperm have fused with hamster oocytes.
It provides precise information on numerical
and gross structural abnormalities of all
chromosomes from a given spermatozoon.
However, only a limited number of sperm
can be evaluated in each assay, and only
those sperm that fertilize the oocytes are ana-
lyzable. Furthermore, this assay is technically
difficult, labor intensive, expensive, and
requires the use of animals (96). Also, it is
better suited for clinical than for ﬁeld studies
because it must be performed on fresh
semen. FISH, on the other hand, relies on
the use of chromosome-specific probes to
detect extra chromosomes (aneuploidy) or
chromosome breaks or rearrangements in
sperm. It is performed directly on sperm
cells, eliminating the need for the use of ani-
mals. Although information is gained only
for several chromosomes at a time, slides can
be reprobed to increase the number of chro-
mosomes evaluated. Furthermore, FISH can
be conducted on archived sperm (either
frozen or dried on slides), making it ideal for
use in field studies. However, because the
incidence of sperm aneuploidy is low, many
cells (up to 10,000 per semen sample) must
be evaluated, which requires signiﬁcant scor-
ing times. In comparison to karyotype analy-
sis, however, FISH is relatively inexpensive
and technically simpler, and data are
obtained on all sperm, not just the ones that
are capable of fertilization. These two tech-
niques complement each other, with FISH
providing information on large numbers of
cells and karyotyping providing more precise
and detailed information (94,97–99).
Several risk factors have been identiﬁed
for increasing sperm chromosomal abnor-
malities. A sperm karyotype study of radio-
therapy patients before and after treatment
demonstrated a significant increase in the
frequency of both numerical and structural
chromosomal abnormalities up to 3 years
after treatment (83). Assessing aneuploidy
rates using FISH in men who received
chemotherapy has yielded varying results
based on agent, dose, timing of specimen
collection, and type of cancer studied. Male
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frequency of chromosomally abnormal
sperm karyotypes (94). These ﬁndings are of
concern because infertile men may be candi-
dates for intracytoplasmic sperm injection
(ICSI), and therefore may be at increased
risk of having children with chromosomal
abnormalities.
Paternal age is another risk factor (96).
Although increasing maternal age is irrefu-
tably associated with an increased risk of
nondisjunction in the oocyte, the relation-
ship between paternal age and the frequency
of nondisjunction has not been clearly eluci-
dated. The father’s influence on the fetus,
however, may begin long before conception.
Fetal development may be affected if the
male has been exposed to lifestyle and/or
occupational hazards. For example, recent
studies show that smoking and/or alcohol
consumption are associated with an increased
risk of sperm aneuploidy (100,101).
Multivariate analyses of national data by the
March of Dimes suggest that paternal factors
such as age or education may play an impor-
tant role in birth outcomes such as low birth
rate and infant mortality (102).
Preliminary data from a study sponsored
by the Czech Ministry of the Environment
and the U.S. EPA (103) demonstrated a sig-
niﬁcant association between exposure to air
pollutants and aneuploidy in sperm. FISH
was used to detect chromosomes X, Y, and 8
in spermatozoa of nonsmoking men 18 years
of age. Men exposed to the heaviest air pol-
lution had an elevated level of sperm with an
extra Y chromosome (YY8), although other
disomies were not increased (103). 
These examples illustrate how genetic
markers are starting to be used in the evalua-
tion of male reproductive health to highlight
subtle but important effects of environmen-
tal risk factors.
Recommendations for the
Future
Despite extensive research into environmen-
tal influences on male reproductive health,
the scope of the problem is still unknown.
Standardized epidemiologic investigations,
including collaborative international studies
of reproductive health parameters in general
populations, may help to improve knowl-
edge; however, deﬁning optimal strategies for
collecting relevant data presents a signiﬁcant
challenge for researchers and clinicians work-
ing in all areas of male reproductive health. 
The determinants of the various end
points of male reproductive health and dys-
function—including infertility, sexual dys-
function, sperm characteristics, and birth
outcomes—are poorly understood. There is
abundant evidence that the male reproduc-
tive system can be inﬂuenced by exposure to
hazardous substances during development,
requiring the incorporation of preconception
periods in both human and in vivo experi-
mental animal studies. However, there is
also limited information about the mecha-
nisms and the impact on male reproductive
function of specific environmental expo-
sures. It is therefore important that clinical
researchers and epidemiologists work with
basic scientists to strategize about what sub-
stances to focus on and how exposures to
these substances can be prevented. 
The ﬁve recommendations for the future
assume that a vital collaboration across disci-
plines and between government and acade-
mic institutions will be the most efficient
and effective way to ﬁll in the many gaps in
knowledge. Moreover, collaborative interna-
tional research will increase the capacity of
researchers to make reliable comparisons of
study populations.
Prioritize hazardous substances. Limited
information is available about the relation-
ship between environmental exposures and
reproductive risk in humans. Most of our
knowledge on this subject comes from stud-
ies of occupational exposures. To design
studies and collect data that will have the
greatest potential to identify and characterize
reproductive risks to humans, it is important
to prioritize known or suspected reproduc-
tive toxicants. 
The evaluation of chronic, intermittent,
and multiple exposures poses some of the
most significant problems in all areas of
environmental research. These kinds of
exposures are difﬁcult to specify and quanti-
fy, and the data needed to elucidate mecha-
nisms of action for many chemicals and
physical agents are often absent or inade-
quate. Although short-term exposure to
environmental contaminants may cause dys-
function in the maturation process of the
spermatozoa, for example, long-term expo-
sures may disrupt neuroendocrine function,
making it difficult to determine the initial
cellular target and mode of causality in
adverse male reproductive health outcomes.
Assessing cumulative risks of exposure to
multiple toxicants is more difﬁcult than eval-
uating chemicals individually. Methods to
examine the effects of complex chemical
mixtures to protect human health in the real
world must be developed. There are gaps in
our understanding of the risks of chronic
exposure to low levels of toxicants such as
pesticides.
The U.S. EPA is required to evaluate
reproductive risks of exposures to pesticides
and other toxic substances, as well as to
develop tests to screen for chemicals with
potential to disrupt the endocrine system.
The U.S. EPA multigeneration reproductive
toxicity test was recently modiﬁed (1998) to
add more speciﬁc indicators of reproductive
organ function such as sperm measures
(104). The revised test is better suited to
detect more subtle effects on spermatogene-
sis and sperm maturation that might not be
of sufficient magnitude to alter fertility in
rodents but could be relevant to assessing
risks in humans. The revised test also
includes evaluation of sexual differentiation
and maturation and is therefore better able to
detect environmental endocrine disruptors
(104). This test and similar tests used by the
U.S. National Toxicology Program are suit-
able for hazard identiﬁcation and are therefore
important sources of information for priori-
tizing chemicals for further research including
determination of the mode of action and cel-
lular/molecular mechanisms of action. 
The U.S. EPA reproductive toxicity tests
and harmonized protocols recommended for
use by the Organisation for Economic Co-
operation and Development (104,105) are
being applied voluntarily by industry to the
large group of high-production volume
(HPV) chemicals for which reproductive
toxicity data are often lacking. HPVs, which
number more than 3,000, are defined as
chemicals produced at a rate of more than
one million pounds per year. A recent evalu-
ation of U.S. EPA chemical data showed
that nearly half (43%) of these HPVs have
not been screened adequately for toxicity
(106). Therefore, the U.S. EPA, albeit a
valuable source of toxicity data, cannot be
the only source of information about priori-
ty substances. Researchers and other govern-
ment agencies must endeavor to deﬁne and
explore other potential hazards.
Evidence of reproductive effects derived
from observations and studies in wildlife
species may provide additional valuable clues
about risks in humans despite interspecies
differences among reproductive systems.
Thus all sources of toxicologic information,
whether obtained in humans, test species, or
wildlife species, should be considered when
prioritizing chemicals for further research.
Elucidate the magnitude of male repro-
ductive health effects. Testicular cancer. The
rising incidence rate of testicular cancer
among young men seems to indicate that
new risk factors have arisen or that influ-
ences from previous factors have intensiﬁed.
Because testicular cancer occurs in young
men, any hypothesis about testicular car-
cinogenesis must consider major etiologic
factors that may operate before conception,
in utero, and early in life. New analytical
studies are needed to further assess risk fac-
tors for this cancer, including assessment of
early infections, low fertility and infertility,
occupational exposures, dietary factors, and
early exposure to abnormal levels of exoge-
nous or endogenous hormones.
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icians assess the incidence and increase
awareness of the risk of testicular cancer
and carcinoma in situ in infertile men.
Furthermore, it is essential to establish
which of the available screening tools (e.g.,
manual testicular exams, scrotal ultrasonog-
raphy, and cytogenetic assays) are feasible
and effective for early detection of testicular
cancer and carcinoma in situ.
Hypospadias and cryptorchidism. More
standardized diagnostic criteria must be
developed so that hypospadias and cryp-
torchidism can be uniformly recognized and
enumerated around the world. This will
allow researchers to move toward an under-
standing of the causes of these disorders. For
their investigation of male reproductive
health, researchers depend not only on labo-
ratory results but also on clinical diagnoses.
It is critical that diagnostic procedures and
classification be comparable around the
world. For example, cryptorchidism, which
resolves spontaneously in 70% of affected
infants by their ﬁrst birthday, should not be
included in surveillance systems until the
ﬁrst birthday. Moreover, clinicians should be
made aware of the importance of develop-
mental age when evaluating infants born
prematurely because it will affect the mor-
phology of the testes. Researchers should
also continue to identify and use existing
reliable data sources and develop additional
surveillance systems for tracking the inci-
dence of these anomalies temporally and
geographically.
Clinical applications. Urologists, repro-
ductive endocrinologists, and other clini-
cians can play a signiﬁcant role in advancing
biomedical research and prevention of
adverse reproductive outcomes. They are on
the front lines in the evaluation and treat-
ment of male reproductive dysfunction;
therefore they can also play a signiﬁcant role
in the collection of data important for study-
ing male reproductive health.
Clinicians should incorporate assessment
of environmental risk factors into their
examination protocol when they evaluate
infertile couples or treat men with reproduc-
tive dysfunction or diseases (75). When men
present with sexual dysfunction, for exam-
ple, clinicians can develop objective means
of differentiating the inﬂuences of environ-
mental factors on sexual functioning from
the inﬂuences of psychologic or physiologic
factors. Currently, methods for such differ-
entiation do exist; for example, by monitor-
ing the frequency and quality of nocturnal
erections. 
When exposure to an environmental tox-
icant is suspected, clinicians should initiate a
physical examination including assessment
of testicular size and abnormalities; a semen
analysis; a hormonal proﬁle; measurements of
speciﬁc toxicants; and, in extreme cases, a tes-
ticular biopsy. Before the initiation of assisted
reproductive techniques such as in vitro fertil-
ization or ICSI, the man should have a
complete work-up, involving, as needed, a
urologist, andrologist, geneticist, and occupa-
tional medicine physician, to investigate the
etiology of the dysfunction or disease.
Clinicians should also initiate prevention
or minimization of known hazards by coun-
seling patients to avoid exposure, to protect
themselves during exposure, and to seek
treatment after exposure. Clinicians can be
the driving force behind public education on
known reproductive hazards.
Because of the clinicians’ critical role, it
is essential that medical schools devote more
teaching time to environmental health issues
and make students aware of the growing spe-
cialty of environmental and occupational
medicine (107).
Clinicians also need accurate informa-
tion about environmental toxicants available
in an efﬁcient format. A centralized source of
reliable information needs to be established
and publicized for physicians who treat male
reproductive dysfunction. An example of
this type of resource has recently been devel-
oped for pediatricians, obstetricians, and
other family care providers. The Handbook
of Environmental Health for Children (108) is
a comprehensive review of known environ-
mental hazards affecting children, as well as
guidance for evaluating, treating, and pre-
venting these exposures.
Develop biomarkers of exposures and
male reproductive health for research and
clinical use. Resources must be invested in
developing more advanced biomarkers of
exposure to reproductive toxicants and of
reproductive health outcomes. Advanced
biomarkers would allow for the develop-
ment of toxicant-specific tests (e.g., poly-
cyclic aromatic hydrocarbon–DNA adducts)
and the detection of subclinical changes that
might have significant health implications
but which now go unnoticed by current
measures. New biomarkers of semen quality
are advantageous in that they can both
describe male reproductive capacity and
indicate toxic effects independent of the
female partner’s reproductive health. New
tests could more accurately measure sperm
function, fertilization potential, and the
transmission of an intact male genome.
Genetic testing may provide valuable tools
for researchers and clinicians. For example,
the sperm chromatin stability assay and
FISH are used to assess genetic structure
after exposure to a potential toxicant.
Recently, single nucleotide polymorphisms
have been used in the assessment of
gene–environment interactions.
Another key element of future research is
the development of a standardized panel of
relevant biomarkers. Individual biomarkers
are often used in isolation to test for one spe-
ciﬁc exposure or type of outcome. However,
a panel of biomarkers may, in combination,
provide a more powerful lens through which
to examine male reproductive capacity and
evaluate toxicity. Therefore, researchers need
to systematically examine correlation among
existing biomarkers and develop standard-
ized panels of complementary biomarkers.
With the current tools it is possible to paint
a more detailed picture of the relationship
between environmental exposures and male
reproductive health than has been previously
understood. When prospective studies are
designed with this approach in mind, epi-
demiologic models can provide data on the
complex kinds of exposure patterns that
undoubtedly have an impact on male repro-
ductive health.
Foster interdisciplinary research. Wildlife
populations. The discoveries made by ecolo-
gists of reproductive abnormalities in wildlife
populations have, in the past, alerted medical
scientists to the possibility of correlated
adverse health outcomes in humans (108).
There are major differences in the endocrine
system across species, so wildlife species must
be studied first without extrapolation to
humans in mind. However, information
about wildlife can be used to guide studies in
laboratory animal models, the results of
which can be used to guide human research
and policy development. The link between
ecologic and biomedical research scientists
needs to be strengthened so that the adverse
health effects of environmental toxicants can
be identiﬁed and studied quickly, with the
goal of prevention. To that end, funding
should be earmarked for collaborative multi-
disciplinary research projects that will bring
specialized diverse researchers together to
focus on common goals. In addition to estab-
lishing collaborative research, funding should
be invested to improve wildlife surveillance.
This will beneﬁt the ﬁeld of wildlife biology
as well as, ultimately, characterization of
wildlife sentinels for human health.
Experimental models. Multigenerational
studies with experimental animals, particu-
larly continuous breeding studies, should be
used to develop paradigms for human stud-
ies. Although animal research is limited in its
correlation to human health outcomes, it is a
critical component of gaining a better under-
standing of male reproductive health.
Animal studies are beneficial because
researchers can control the route and dose of
exposure to the suspected toxicant as well as
mixtures of toxicants, researchers can look at
a wide variety of specific end points, the
studies have fewer confounding factors than
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mals are genetically homogenous. Animal
research thus allows for the determination of
a toxicity threshold that can then be extrapo-
lated to humans.
It is not enough to know that a sub-
stance is toxic to the male reproductive
system. Scientists must also examine the
mechanisms of toxicity. Mechanistic under-
standing facilitates making predictions
about the potential toxicity of individual
compounds or complex mixtures, enhances
our understanding of the windows of vul-
nerability in the development of the male
reproductive system, and contributes to the
development of improved screening tests
(including in vitro tests). Animal research is
an important means of determining the
mechanisms of toxicity, and research must
proceed in this area. Furthermore, animal
data can be used to help formulate hypothe-
ses and design epidemiologic studies in
humans, and in turn, human studies can
inform toxicology experiments.
Epidemiology. The evidence generated
from studies of wildlife and experimental
models should guide the development of
prospective epidemiologic studies that focus
on specific outcomes and measure specific
toxicants. Epidemiologists should aim to
study populations that are consistent geo-
graphically and over time, so that they may
avoid confounding factors which can dilute
observed associations. Appropriate prospec-
tive studies are needed to address geographic
variability while taking into consideration or
controlling other important variables. These
include methods of selecting the study popu-
lation and methods of semen analysis;
seasonal variation; ethnic variation; and mea-
surable environmental factors.
One of the barriers to research in male
reproductive health is the perceived or actual
difficulty in obtaining semen samples.
Epidemiologists should aim to increase
response rates in their studies through indi-
vidualized contact with the study subjects,
limited ﬁnancial incentives, and convenient
collection methods.
Existing surveillance systems may be
valuable data sources for occupational repro-
ductive health research. Exposure registries
for workers exposed to known reproductive
toxicants such as heavy metals, pesticides,
and radiation, for example, could be used to
develop epidemiologic cohorts. Ongoing
examination of available data will clarify the
extent to which existing surveillance systems
can be used.
Standardized birth information forms
would greatly aid epidemiologic research in
the area of male reproductive health. There
is a need to convene a working group to a)
develop standardized data collection to
ensure that equivalent data on potential
parental exposures or risk factors are
obtained worldwide and b) more reliably
evaluate environmental exposures or other
risk factors during critical periods of devel-
opment. The development and implementa-
tion of uniform computerized records will
allow for a more precise understanding of
routinely collected data in the future. The
systems used in Scandinavian countries can
serve as a model for this kind of standardiza-
tion (109). It is also important to increase
the type of information collected on birth
certiﬁcates so that these vital statistics may,
in the future, provide the basis for useful ret-
rospective cohort studies.
At present, recommendations for data
collection at birth in the United States are
made nationally but states implement their
own systems. Therefore, there is a clear need
for national standards. A working group of
experts should be convened to generate com-
puterized pre-, peri-, and postnatal forms for
clinicians to use. Although there are draw-
backs to computer dependence including
limited computer access in some settings, an
enormous volume of data management, and
the complexity of quality assurance and con-
trol, the beneﬁts of standardized data collec-
tion outweigh the limitations.
Recognize the importance of standard-
ized laboratory methods and sample archiv-
ing. Scientists need to be able to compare
data obtained through laboratory testing.
However, many of the laboratory methods
for assessing male reproductive health are
not standardized, which means not only that
different laboratories will generate different
results using the same sample but also that
the results of the same sample within one
laboratory may be different when analyzed at
different times. Centralization of laboratories
is not necessary but standardization of
methodologies is necessary. Quality control
initiatives involving research and clinical lab-
oratories are necessary to ensure reliability of
data. It is critical that the international
research community develop standards by
which laboratory testing can become more
accurate and more precise. This need for
standardization applies to exposure as well
as outcomes assessment. This will allow for
a better characterization of international
comparisons or trends in male reproductive
health. These programs would encompass
tissue archives, including pathologic speci-
mens from tumors, blood banks, and semen
banks. Research should be developed that
will incorporate the use of archived tissue to
provide as broad a picture of male reproduc-
tive health as possible. It is important to
continue to archive tissue and develop
strategies to maximize multiuse research in
the future.
Summary
From changes observed in wildlife, to
increasing rates of testicular cancer, to the
debate regarding trends in sperm counts,
there has been increasing concern that haz-
ardous substances in the environment
adversely affect male reproductive health.
Our ability to fully address the impact of
hazardous substances has been hampered by
limitations on sources of relevant data and
appropriate research methodologies. The
recommendations summarized in this paper
should serve as a framework for future stud-
ies to improve our knowledge in this area.
By better defining the problems, learning
about the mechanisms responsible for
adverse effects, and developing panels of rel-
evant biomarkers, we will make progress
toward preventing future adverse effects on
male reproductive health.
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